Authors
Loading...
Analysis of cd44 variants and structures in protein databases identifies possible small-molecule inhibitors, suggesting new targets for cancer therapy.
Gerlicz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: